Robot-assisted Walking Treatment in Hereditary Spastic Paraplegia (HSP)
Recruiting
Observational Study
Hereditary Spastic Paraplegia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 4 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- IRCCS Eugenio Medea · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients will undergo a combined rehabilitation treatment consisting of 15 sessions on Lokomat and 15 sessions of physical therapy over three weeks for a total of 30 sessions. Two sessions/day for 5 days a week. The same subjects will conduct clinical-functional assessments before, at the end of treatment, and after a 3-month follow-up:
3D Gait Analysis with defined protocol (BTSBioenginner); Spa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* genetic or clinical diagnosis of HSP.
* age greater than 4 years and less than 70
* femur length \> 23 cm
* ability to walk independently indoors, with or without walking aids.
Exclusion Criteria:
* botulinum toxin injection or lower limb surgery in the previous 6 months
* s…
Contacts